Printer Friendly

Browse Respiratory agents topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
United Kingdom : GSK receives FDA approval for Arnuity Ellipta (fluticasone furoate) in the USA for the treatment of asthma. Aug 22, 2014 304
Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms. Aug 21, 2014 679
GSK receives FDA approval for Arnuity(TM) Ellipta (fluticasone furoate) in the US for the treatment of asthma. Aug 20, 2014 924
Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD. Aug 19, 2014 2156
FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD. Aug 14, 2014 1485
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 594
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 599
Concordia Healthcare Corp. initiates Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN[R]. Aug 5, 2014 1189
Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients. Clinical report Aug 4, 2014 908
Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients. Clinical report Aug 4, 2014 915
FDA Approves Boehringer Ingelheim's Striverdi Respimat (olodaterol) Inhalation Spray for Maintenance Treatment of COPD. Aug 1, 2014 1508
Drugs for Lung Disease Work With Body Clock. Jul 28, 2014 480
Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma. Jul 24, 2014 679
Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse. Jul 23, 2014 726
United Kingdom : Intertek co-author study on inhaled medicine test procedures. Report Jul 22, 2014 331
Children's growth 'being stunted by asthma inhalers'. Jul 18, 2014 288
Asthma Inhalers Can Stunt Child Growth. Jul 18, 2014 363
New genes identified to help in asthma treatment. Jul 9, 2014 289
United Kingdom,United States : Anoro Ellipta (umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD. Jul 7, 2014 446
Japan,United Kingdom : Anoro Ellipta(umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD. Jul 4, 2014 436
United Kingdom : GSK and Theravance announce submission to US regulatory authorities for fluticasone furoate/vilanterol in asthma. Jul 1, 2014 324
Pulmonary Drug Delivery Systems Market (Products - Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications - Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019. Jun 23, 2014 2089
Emerging Therapies for Previously Treated EGFR Wild-Type/Untested Non-Small-Cell Lung Cancer are Expected to Offer Efficacy Benefits Over Current Treatments. Jun 19, 2014 656
Asmacure Announces Top-Line Clinical Results for ASM-024 DPI in Ph 1/2a Trial. Financial report Jun 18, 2014 1192
Hunterdon Regional Cancer Center: The Only Cancer Center in New Jersey to Offer Immuno-Therapy Clinical Trial for Lung Cancer. Jun 11, 2014 743
DelMar Pharmaceuticals, Inc. Presentation Now Available for On-Demand viewing at RetailInvestorConferences.com. Jun 9, 2014 689
Yoga may not be of much help to asthma sufferers. Jun 3, 2014 197
Parion Sciences Announces Senior Leadership and Organizational Changes. Jun 2, 2014 814
Fears for kids over asthma inhalers. Jun 1, 2014 185
AADI SIGNS LICENSING AGREEMENT WITH CELGENE. Jun 1, 2014 412
Drugs approved in 2013. Briggs, Gerald G. Jun 1, 2014 1467
Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA). May 29, 2014 1548
Xencor Initiates Phase 1 Study of XmAb7195 for Asthma. May 28, 2014 751
Immune Design's GLAAS(TM) Discovery Platform Used in MEDI7510 Phase 1 Trial for Respiratory Syncytial Virus. May 27, 2014 631
New Potential Antibody Treatment for Asthma Discovered. May 23, 2014 445
DelMar Pharmaceuticals to Present at the Third Annual Marcum LLP MicroCap Conference. Conference news May 22, 2014 781
Singapore : ASLAN PHARMACEUTICALS obtains global license to develop Asthma Treatment. May 22, 2014 213
Potential asthma treatment discovered. May 21, 2014 342
Boehringer Ingelheim Presents First Phase 3 Data on Fixed-Dose Combination of Tiotropium Plus Olodaterol in COPD. May 21, 2014 1480
AADi Announces Licensing Agreement with Celgene for Nanotechnology-Based Drug Candidate. May 20, 2014 684
The New England Journal Of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment. Clinical report May 20, 2014 2113
Vitamin D has limited benefits in asthma treatment. May 19, 2014 404
Leading Pulmonologists Draw National Media Focus to Endobronchial Coil Treatment for Severe Emphysema. May 19, 2014 1028
Ataluren Phase 3 Trial Results in Nonsense Mutation Cystic Fibrosis Published in The Lancet Respiratory Medicine. May 16, 2014 1724
Prosonix to Present Results of Phase 2 Clinical Study of PSX1002 in Chronic Obstructive Pulmonary Disease (COPD) at the American Thoracic Society Meeting. Clinical report May 15, 2014 1010
Prosonix to Present Results of Phase 2 Clinical Study of PSX1002 in Chronic Obstructive Pulmonary Disease (COPD) at the American Thoracic Society Meeting. Clinical report May 15, 2014 1006
DelMar Pharmaceuticals to Present Interim Clinical Data for Ongoing VAL-083 Glioblastoma Multiforme Trial at ASCO. May 14, 2014 563
FLUIDDA'S Technology Assists in Optimizing Treatment for COPD Patients. May 9, 2014 270
FLUIDDA'S Technology Assists in Optimizing Treatment for COPD Patients. May 9, 2014 274
United Kingdom : Anoro (umeclidinium/vilanterol) gains marketing authorisation in Europe for the treatment of COPD. May 9, 2014 348
Study Shows No Benefit From Active Ingredient In Common Cold Medicine. May 8, 2014 540
United Kingdom : GSK receives approval for Incruse Ellipta (umeclidinium) in the US for the treatment of COPD. May 2, 2014 334
Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors. Apr 30, 2014 508
GSK receives approval for Incruse(TM) Ellipta (umeclidinium) in the US for the treatment of COPD. Apr 30, 2014 1162
United Kingdom : GSK receives EU marketing authorisation for Incruse (umeclidinium) for the treatment of COPD. Apr 29, 2014 452
Anoro(TM) Ellipta now available in the US for treatment of COPD. Apr 28, 2014 2169
Erdosteine Received Orphan Drug Status by the FDA. Apr 28, 2014 1006
Greater Reductions in Exacerbations Remains an Open Area of Opportunity in the Chronic Obstructive Pulmonary Disease Market. Apr 24, 2014 691
Genoa Pharmaceuticals and McMaster University demonstrate inhaled pharmacokinetics enables improved pirfenidone activity with significant promise to enhance IPF treatment safety and tolerability. Apr 21, 2014 627
COPD Drug Market Opportunity and Clinical Pipeline Analysis. Apr 19, 2014 1284
COPD Drug Market Opportunity and Clinical Pipeline Analysis. Apr 19, 2014 1289
United Kingdom : GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD. Apr 18, 2014 298
Cough medicine'put driver over drink limit'. Apr 11, 2014 148
United Kingdom : VALIRX partners with TANGENT REPROFILING to advance treatment for lung cancer. Apr 8, 2014 181
DelMar Pharmaceuticals Presents Promising Pre-clinical Data with VAL-083 in Lung Cancer. Apr 7, 2014 1263
DelMar Pharmaceuticals to Present Two Abstracts at American Association of Cancer Research (AACR) Annual Meeting. Apr 2, 2014 714
Nasal spray delivers new type of depression treatment. Mar 24, 2014 645
Specialised Therapeutics Australia Receives Therapeutic Goods Administration Approval for Abraxane(R) in Combination with Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer. Mar 18, 2014 2028
Landmark Year in Sleep: Leader in Sleep and Respiratory Medicine Highlights Top Five Sleep Apnea Research Findings. Mar 14, 2014 1022
Landmark Year in Sleep: Leader in Sleep and Respiratory Medicine Highlights Top Five Sleep Apnea Research Findings. Mar 14, 2014 1027
Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019. Industry overview Mar 7, 2014 633
Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019. Industry overview Mar 7, 2014 681
Alexza Announces the U.S. Commercial Launch of ADASUVE by Teva Pharmaceuticals. Mar 3, 2014 2456
Boehringer Ingelheim Presents Phase 3 Data for Tiotropium Across Asthma Severities. Mar 1, 2014 2762
Phenotypes may increase targeted pulmonary therapies. Mcknight, Whitney Mar 1, 2014 912
ONY Inc., A Pioneer In Neonatal Pharmaceutical Development, Has Entered Into A Co-Promotion Agreement With Recordati Rare Diseases For NeoProfen. Feb 26, 2014 1912
Pulmonary Drug Delivery Systems Market Expected to Reach USD 28.7 Billion Globally in 2019: Transparency Market Research. Feb 25, 2014 1441
Pulmonary Drug Delivery Systems Market Expected to Reach USD 28.7 Billion Globally in 2019: Transparency Market Research. Feb 25, 2014 1461
United Kingdom : GSK receives positive CHMP opinion for Incruse (umeclidinium) for the treatment of COPD. Feb 21, 2014 264
United Kingdom : Anoro (umeclidinium / vilanterol) receives positive opinion from the CHMP in Europe for the treatment of COPD. Feb 21, 2014 340
Passive smoking dangerous for asthmatic kids. Feb 17, 2014 209
Kids exposed to passive smoke respond less to asthma treatment. Feb 16, 2014 173
Clinical Trial Shows eNT Inhaler Produces Rapid and Significant Reductions in Smoking Urge. Feb 14, 2014 887
StemGenex Announces Newest Stem Cell Treatment for COPD Patients. Feb 11, 2014 469
France : SKYEPHARMA intros flutiform asthma treatment in FRANCE. Feb 11, 2014 149
AIT's Phase II Clinical Trial for Cystic Fibrosis Adds Schneider Children's Medical Center of Israel as Second Site in Expanded Trial. Feb 10, 2014 748
Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Jan 23, 2014 1189
Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Jan 23, 2014 1193
Chiesi respiratory r&d project. Jan 21, 2014 245
Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations. Jan 14, 2014 1121
AIT Announces Phase II Study of NOxCureCF, a Respiratory Treatment for Cystic Fibrosis Patients Using a Nitric Oxide-Base Formulation. Report Jan 7, 2014 854
Drug Device Combination Products Market is Expected to Reach USD 115.1 Billion Globally in 2019: Transparency Market Research. Dec 24, 2013 1214
Drug Device Combination Products Market is Expected to Reach USD 115.1 Billion Globally in 2019: Transparency Market Research. Dec 24, 2013 1234
United Kingdom : ANORO ELLIPTA approved as first once-daily dual bronchodilator for the treatment of COPD in the US. Dec 19, 2013 446
FLUIDDA Presents Novel Imaging Technology for Respiratory Diseases to FDA. Dec 18, 2013 479
Hovione: New Inhalation Capsule Filling Machine Fills Market Gap. Dec 5, 2013 520
Dr. Yamo Deniz to Join Cytos Biotechnology's Board of Directors. Dec 4, 2013 1040
Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment. Dec 3, 2013 822
Racial and ethnic differences in childhood asthma treatment in the United States. Sarpong, Eric M.; Miller, G. Edward Dec 1, 2013 9224
Paediatric spirometry guideline of the South African Thoracic Society: Part 1. Masekela, R.; Gray, D.; Verwey, C.; Halkas, A.; Jeena, P.M. Dec 1, 2013 5018
United Kingdom : Cough and cold medicines recalled by Boots UK. Nov 28, 2013 278
Boots recalls kids cough medicines. Nov 27, 2013 102
Boots recalls cough medicine; NEWS IN BRIEF. Nov 27, 2013 119
United Kingdom : RELVARA ELLIPTAA receives European marketing authorisation for the treatment of asthma and COPD. Nov 19, 2013 102
Germany : Boehringer Ingelheim submits applications in Europe to extend the indication for the use of tiotropium RespimatA to the treatment of asthma in adults aged 18 years and over. Disease/Disorder overview Nov 14, 2013 406
Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents. Nov 12, 2013 700
Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. Gorgan, Maria; Bockorny, Bruno; Lawlor, Michael; Volpe, John; Fiel-Gan, Mary Report Nov 1, 2013 2553
Asthma triggers: Pets and plants. Oct 31, 2013 435
BREO ELLIPTA(TM) now available in the U.S. for the treatment of COPD. Oct 30, 2013 2172
AIIMS researchers prove yoga's benefits for COPD patients. Oct 29, 2013 252
Milestone Pharmaceuticals Initiates a Phase 1 Clinical Trial with MSP-2017. Oct 28, 2013 433
New Data Provides Further Evidence of Lung Function Improvements in Severe Asthma with Tiotropium Delivered via the Respimat Inhaler. Oct 28, 2013 1783
United States : GSK submits NDA for asthma treatment. Oct 28, 2013 158
KaloBios Elects Laurie Smaldone Alsup, M.D. to Board. Oct 23, 2013 1120
Germany : New once-daily Striverdi (olodaterol) Respimat gains approval in first EU countries. Oct 19, 2013 413
Celtaxsys Initiates First Clinical Trial of Oral CTX-4430 Therapy in Cystic Fibrosis Patients. Oct 10, 2013 531
IceCure Enters a New High-Potential Market: The company received $100K-order for cryoablation consoles and probes to be used in a clinical study for the treatment of lung cancer. Clinical report Oct 1, 2013 728
Principles of pulmonary medicine, 6th ed. (online access included). Brief article Oct 1, 2013 150
Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+. Sep 29, 2013 690
Successive supply of various parenteral and inhaled medications . Sep 27, 2013 200
United Kingdom : RELVAR ELLIPTA gains approval in Japan for the treatment of asthma. Sep 21, 2013 422
United Kingdom : RELVAR ELLIPTA receives positive opinion from the CHMP in Europe for the treatment of asthma and COPD. Sep 20, 2013 115
New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments. Sep 19, 2013 648
Lyrica[R] (pregabalin) capsules[v]. Sep 15, 2013 6182
Hovione: EPO Grants a New Inhaler Patent. Sep 11, 2013 565
Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity. Sep 10, 2013 2226
Landmark TIOSPIR(TM) Trial Further Reinforces Safety and Efficacy Profile of Spiriva Respimat in the Treatment of COPD. Sep 8, 2013 2261
Landmark TIOSPIR(TM) trial demonstrates comparable long-term safety of tiotropium delivered via Respimat and HandiHaler in COPD patients. Sep 8, 2013 1999
Olodaterol Shows Sustained Improvements in Lung Function in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Sep 8, 2013 2574
Verifying the role of surgical pathologists in the precision medicine of lung cancer. Cagle, Philip T.; Olsen, Randall J. Editorial Sep 1, 2013 2991
Lung cancer biomarkers: present status and future developments. Cagle, Philip T.; Allen, Timothy Craig; Olsen, Randall J. Report Sep 1, 2013 8804
Cardiovascular and respiratory generic medicines. Aug 31, 2013 144
Final Patient Completes Prosonix' Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Aug 16, 2013 1042
Final Patient Completes Prosonix' Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Aug 16, 2013 1046
Understanding respiratory medicine; a problem-oriented approach. (reprint, 2006). Book review Aug 1, 2013 110
The impact of pulmonary tuberculosis treatment on the prevalence of allergic rhinitis. Lin, Carren Teh Sui; Krishnan, Gopala; Manuel, Anura Michelle Aug 1, 2013 2611
First in Class Once-Daily Dual Bronchodilator Ultibro Breezhaler (QVA149) Gains Positive CHMP Opinion for the Treatment of COPD. Jul 27, 2013 2801
Doctors to join study into treatment of lung cancer. Jul 19, 2013 478
Soon, nasal spray that could put an end to painful dentist injections. Jul 5, 2013 167
Gene clues show which children will grow out of asthma. Jul 5, 2013 322
Housemaid in Dubai arrested for giving baby cough medicine. Jun 29, 2013 579
Cough suppressant may ease fibromyalgia pain. Jun 20, 2013 449
Inspiro Medical Ltd. Completes a Successful First Clinical Trial in Asthmatic Children. Jun 6, 2013 452
Genoa Pharmaceuticals and McMaster University demonstrate in vivo benefit of inhaled pirfenidone offering greater pulmonary fibrosis efficacy than oral therapy. Jun 5, 2013 665
EGEN, Inc. Advances a Systemically Delivered RNAi Therapeutic for the Treatment of Pulmonary Arterial Hypertension (PAH). Jun 5, 2013 888
Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program. Jun 4, 2013 544
DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting. May 28, 2013 604
Record Donation of Respiratory Medicines Headed to U.S. Clinics. May 28, 2013 872
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). May 22, 2013 929
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). May 22, 2013 933
Phase III Results: Once-daily Tiotropium* Effective in Symptomatic Asthma Patients Irrespective of Their Age, Allergic Status, Smoking Status and Bronchodilator Response. May 21, 2013 2478
Asmacure Highlights Four Presentations on Novel Pulmonary Development Compound ASM-024 Presented at American Thoracic Society 2013 International Conference. Conference news May 20, 2013 1262
France : Stallergenes and DBV Technologies enter into partnership for the development of innovative treatment of respiratory allergies. May 17, 2013 208
Asmacure to Present Four Posters on Novel Pulmonary Development Compound ASM-024 at American Thoracic Society 2013 International Conference. Conference news May 16, 2013 773
United States : FDA cleared requests of THERAVANCE & GSK for COPD Medicine. May 13, 2013 312
United Kingdom : BREO ELLIPTA gains US approval for the treatment of COPD. May 11, 2013 333
BREO(TM) ELLIPTA(TM) gains US approval for the treatment of COPD. May 10, 2013 2185
Asthma treatment cannot be cure but allows patient to live normally. May 8, 2013 719
Asthma treatment can not be the cure but allows patient to live normally. May 7, 2013 728
Warfarin replacements: good for patients, challenging for laboratories. Eby, Charles S. Editorial May 1, 2013 1844
ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment. Apr 25, 2013 834
Switzerland : Novartis once-daily QVA149 shows superior efficacy in reducing exacerbations, improving lung function and quality of life in COPD patients. Apr 24, 2013 405
Cancer Experts Detail Advanced Radiosurgery Treatments for Lung Cancer Using Varian Medical Systems Technologies. Apr 22, 2013 869
United Kingdom,United States : FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD. Apr 18, 2013 463
FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD. Apr 17, 2013 1676
'Make new lung drug available' HEALTH. Apr 16, 2013 151
Asmacure Dosed First Subjects With ASM-024 Dry Powder For Inhalation. Apr 15, 2013 868
VERONA PHARMA PLC - Final Results. Company overview Apr 10, 2013 5431
DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting. Apr 1, 2013 586
Nelson Mandela 'Responding' to Treatment for Lung Infection. Mar 29, 2013 312
Exposure to Inhaled Agents at Work Means 1 in 4 of Operated Chronic Sinusitis Patients Fail to Recover. Mar 21, 2013 800
VERONA PHARMA PLC - RPL554 demonstrates airway anti-inflammatory activity. Mar 5, 2013 1330
Acute asthma treatment guidelines: reducing morbidity and mortality in South Africa. Zar, H.J.; Lalloo, U.G. Mar 1, 2013 2025
KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma. Feb 26, 2013 1402
Bioscience Managers Expands Asia Pac Presence -- Invests NZ$3m in NZ Patient Monitoring Company. Feb 21, 2013 1478
Fungi in lungs may hold asthma treatment clues. Feb 20, 2013 342
Celebrity health clinic; Vital health Asthma affects many athletes, but they don't let it stop them achieving their goals. Feb 13, 2013 265
China,Japan,Korea Republic of,Taiwan Province of China,United Kingdom,United States : OXONC and PFIZER ink co-development agreement for pivotal clinical trial of Crizotinib. Feb 11, 2013 267
Watson supercomputer to assess treatments for lung cancer and manage health insurances. Feb 10, 2013 371
Vitamin and mineral treatment in asthma. Singh, Aminder; Feuerstein, Lindsay Feb 1, 2013 2509
China : SFDA grants production license for Pholcodine to AOXING PHARMA. Jan 29, 2013 133
FDA Advisory Committee Recommends Approval for Boehringer Ingelheim's Olodaterol for Maintenance Treatment of COPD. Jan 29, 2013 939
Cough suppressant may ease fibromyalgia pain. Jan 9, 2013 452
Belgium : Cost evaluation of treatment modalities in cancer patients. Jan 4, 2013 232
Celtaxsys Initiates Phase 1 Study of CTX-4430 Oral Treatment for Pulmonary Inflammation. Jan 3, 2013 524
Enhance your research and professional presentations. Rapple, Lisa Jan 1, 2013 1340
FDA Grants Accelerated Approval for SIRTURO(TM) (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis. Dec 31, 2012 2432
My fight to save asthma wonder drug; 'TOO COSTLY' TREATMENT UNDER THREAT. Dec 27, 2012 363
In the Asthma Drug Market, Generic Erosion Will Reduce Sales of Merck/Kyorin's Singulair by More Than $2.8 Billion Between 2011 and 2021. Dec 19, 2012 552
National Survey Finds Less Than 5 Percent of Teens Abuse OTC Cough Medicine. Dec 19, 2012 420
Forest Laboratories and Almirall announce commercial availability of Tudorza[TM] Pressair[TM] in US pharmacies. Dec 11, 2012 1083
iSonea Previews AsthmaSense v1.1 at mHealth Summit. Dec 3, 2012 1267
Monthly Miracles: exceptional pulmonary therapies Part 1 and the IRR (infraspinatus respiratory reflex). Gerber, Michael Clinical report Dec 1, 2012 2316
Lung cancer genotype-based therapy and predictive biomarkers: present and future. Cagle, Philip T.; Allen, Timothy Craig Dec 1, 2012 12965
Evolving frontlines in the diagnosis and treatment of pulmonary diseases. Cagle, Philip T. Dec 1, 2012 877
A rare cause of faecal peritonitis: jejunal perforation in a patient undergoing treatment for pulmonary tuberculosis. Patel, Sheena; Al-Nowfal, Abdullah; Gould, Stuart T.W. Case study Dec 1, 2012 1310
Anova Cancer Care Brings Future of Lung Cancer Treatment to Denver. Nov 29, 2012 770
Research and Markets: Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update. Nov 28, 2012 457
Interviewed EU5 Payers Stress that Demonstrating Superior Efficacy Over Leading Current Therapies in Head-to-Head Trials is Crucial for Favorable Reimbursement of LABA/LAMA Fixed-Dose Combinations. Nov 27, 2012 821
Dear Dr Miriam. Nov 19, 2012 173
Dear Dr Miriam I [...]. Nov 19, 2012 173
Dear Dr Miriam. Nov 19, 2012 170
Research and Markets: Global Pulmonary Hypertension Drug Pipeline Capsule - 2012 Update. Nov 16, 2012 437
Savara Pharmaceuticals' AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients. Clinical report Nov 13, 2012 808
FDA Accepts GeNO LLC Filing of New Drug Application for GeNOsyl(TM) MVG-2000 Nitric Oxide Delivery System. Nov 13, 2012 754
Research and Markets: Global Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update. Nov 9, 2012 381
LUNGevity Foundation And Take Aim at Cancer Join Together To Raise Awareness And Funds For Lung Cancer Research. Nov 8, 2012 656
Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan. Nov 7, 2012 760
Interim Results of the Phase 2b GALAXY Trial to be Presented at the Chemotherapy Foundation Symposium. Nov 7, 2012 903
Kamada Announces New Data on its Glassia Drug Supporting its Diabetes Activities and Treatment of Additional Therapeutic Indications. Nov 6, 2012 1609
New target for lung cancer treatment identified. Nov 2, 2012 153
Varian Medical Systems Highlights a Comprehensive Product Portfolio for the Non-Invasive Treatment of Lung Cancer. Oct 31, 2012 1115
Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe. Oct 25, 2012 1790
Germany : Bayer s Xarelto (Rivaroxaban) Recommended for EU Approval for the Treatment of Pulmonary Embolism (PE) and Prevention of Recurrent Deep Vein Thrombosis (DVT) and PE. Oct 20, 2012 450
MAP Pharmaceuticals Resubmits New Drug Application to FDA for LEVADEX Orally Inhaled Migraine Drug. Oct 16, 2012 364
Imbio Commercializing Technology to Improve COPD Diagnosis and Treatment. Oct 16, 2012 345
Inhaled Vaccines May Replace Needles. Oct 16, 2012 497
VERONA PHARMA PLC - RPL554 Phase I/IIa data presented at ISAF 2012. Oct 12, 2012 779
Research and Markets: Chinese Markets for Respiratory Drugs Report Features Forecasts up to 2021. Oct 12, 2012 266
The COPD Drug Market Will Become More Fractured as Several New Agents Reach the Market and Erode the Dominance of the Current Market Leaders. Oct 9, 2012 528
New Clinical Study from Rational Therapeutics Doubles Response Rate in Patients with Advanced Lung Cancer; Personalized Treatment for Lung Cancer Comes of Age. Clinical report Oct 8, 2012 415
Research and Markets: Key Findings from Treatment Algorithms: Asthma. Oct 8, 2012 349
Research and Markets: Chinese Markets for Asthma Treatment Drugs Report Gives Long-term Forecasts through 2016 and 2021. Oct 8, 2012 274
Maxwell Biotech Venture Fund Invests in Pivotal Clinical Trial of Oxagen's Drug Candidate for Asthma Treatment. Company overview Oct 4, 2012 1063
SignaBlok Awarded NCI Grant to Test New Approach to Lung Cancer Treatment. Oct 3, 2012 446
Advancing personalized cancer medicine in lung cancer. MacConaill, Laura E. Oct 1, 2012 5339
The transformation of pathology: proceedings of the Houston Lung Symposium. Cagle, Philip T. Oct 1, 2012 956
Precision medicine for lung cancer: role of the surgical pathologist. Cagle, Philip T.; Myers, Jeffrey Oct 1, 2012 3559
Seebri Breezhaler Receives European Commission Approval as Once-Daily Maintenance Treatment for COPD in the EU. Oct 1, 2012 2568
Seebri Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan. Sep 28, 2012 2391
Compounding respiratory medications for homecare patients. Wyka, Kenneth A. Sep 22, 2012 1011
Galleon Pharmaceuticals Reports Positive Results from Second Phase I Study of GAL-021 for Treatment of Respiratory Depression. Sep 20, 2012 521
United States : Cystic Fibrosis Foundation Therapeutics and Pulmatrix Initiate Collaboration to Accelerate PUR118 in the Treatment of Cystic Fibrosis. Sep 15, 2012 463
Stopping LABA therapy may worsen asthma. Moon, Mary Ann Sep 15, 2012 610
Cystic Fibrosis Foundation Therapeutics and Pulmatrix Initiate Collaboration to Accelerate PUR118 in the Treatment of Cystic Fibrosis. Sep 14, 2012 712
UK Hospitals Commence Advanced Stereotactic Lung Cancer Treatments Using RapidArc Radiosurgery. Sep 6, 2012 934
sthma inhalers can stunt growth in children. Sep 4, 2012 512
Alnylam Presents Complete Results from Phase IIb Trial with ALN-RSV01, an Inhaled RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection. Sep 4, 2012 2166
iSonea's AsthmaSense Smartphone App Now Free. Sep 4, 2012 1118
Asthma Steroid Treatments In Childhood Make For Slightly Shorter Adults. Sep 4, 2012 409
Phase III Results: Once-daily tiotropium Significantly Increases Time to First Severe Exacerbation and Reduces the Risk of Exacerbations in Asthma Patients Still Symptomatic Despite ICS/LABA Treatment. Sep 3, 2012 2411
Effectiveness of cognitive behavioral therapy a long with conventional treatment in asthma patients compared with solely conventional therapy. Jamalimotlagh, Maryam; Rezaei, Omid; Fata, Ladan; Jamaati, Hamidreza; Masafi, Saeede Report Sep 1, 2012 4102
Pulmatrix Announces Presentations at European Respiratory Society Annual Congress for Lead Inhaled iCALM Drug Candidate, PUR118. Aug 27, 2012 490
Israel : TEVA bags approval from FDA to market generic asthma treatment. Aug 7, 2012 133
Kamada and Chiesi Enter into a Strategic Agreement for the Distribution of Kamada's Inhaled AAT Drug for Treatment of Alpha-1 Antitrypsin Deficiency in Europe, Turkey and Former CIS Countries. Aug 6, 2012 987
Twice-daily inhaler for COPD. Aug 1, 2012 242
French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil. Jul 30, 2012 699
Almirall and Forest Laboratories Announce FDA Approval of Tudorza(TM) Pressair(TM) for the Long-term Maintenance Treatment of COPD. Jul 24, 2012 1787
Forest Laboratories and Almirall Announce FDA Approval of Tudorza[TM] Pressair[TM] for the Long-Term Maintenance Treatment of COPD. Jul 23, 2012 1663
Elsevier Launches New Open Access Journal: Respiratory Medicine Case Reports. Jul 19, 2012 811
Research and Markets: Asthma and COPD Drug Market - Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts, 2010 - 2017. Industry overview Jul 12, 2012 390
New Federal Legislation Can Help Combat Teen Cough Medicine Abuse. Jul 11, 2012 958
Prosonix Enters Collaboration With Imperial College London to Accelerate Development of Engineered Combination Respiratory Medicines (Multi-component Particles(TM), MCPs(TM)). Jul 5, 2012 761
Positive European Commission Decision on flutiform (fluticasone propionate/formoterol fumarate), a New Combination Therapy for Asthma. Jul 3, 2012 932
Forced expiration exercises in asthma and their effect on FEV. Thompson, Bernice; Thompson, H.T. Report Jul 1, 2012 2334
Research and Markets: Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2019. Jun 27, 2012 405
MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF). Company overview Jun 20, 2012 1081
Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research. Jun 18, 2012 1261
Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-l[alpha] and caspase-3 mechanisms. Ye, Ming-Xiang; Zhao, Yi-Lin; Li, Yan; Miao, Qing; Li, Zhi-Kui; Ren, Xin-Ling; Song, Li-Qiang; Yin, Report Jun 15, 2012 5578
Aeris Therapeutics Receives US Patent 8,198,365 with Broad Claims to Methods of Non-Surgical Lung Volume Reduction. Jun 13, 2012 420
Frost & Sullivan Recognizes Sanovas for its Path-Breaking Innovation in the Treatment of Pulmonary Disease. Company overview Jun 12, 2012 1371
Phase III Study: Patients With Most Common Type Of Lung Cancer Lived Longer With ALIMTA-Based Continuation Maintenance Therapy. Jun 4, 2012 2319
Hope For Late-Stage Lung Cancer? Two-Drug Combo Activates Genes That Help Tumors Self-Destruct. Jun 1, 2012 389
Lung fibrosis in deceased HIV-infected patients with Pneumocystis pneumonia. Shaddock, E.J.; Richards, G.A.; Murray, J. Report Jun 1, 2012 2811
LABA/ICS Fixed-Dose Combinations Are the Most Commonly Prescribed Maintenance Therapies for Newly Diagnosed COPD Patients. May 24, 2012 468
Asthma medication may up arrhythmias risk in kids and young adults. May 23, 2012 744
Leading Researchers Address Hope For Early Detection and Treatments For Lung Cancer. May 17, 2012 1643
Pulmatrix Announces Presentations at ATS 2012 International Conference. Conference news May 16, 2012 628
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease. Clinical report May 16, 2012 1137
Liquidia Studies Show PRINT[R] Engineered Particles Hold Promise in the Delivery of Respiratory Therapeutics. May 15, 2012 1141
Acupuncture may benefit patients with chronic obstructive pulmonary disease. May 15, 2012 331
Pulmonx Reports New Publication Confirms Efficacy of Emphysema Treatment. Clinical report May 10, 2012 1015
Galleon Pharmaceuticals Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression. May 7, 2012 433
Buying Asthma Medication Online Can be Safe and Affordable. May 2, 2012 803
Naturopathic management of infections of the heart and their sequelae. Mikolai, Jeremy; Wilner, Martin Clinical report May 1, 2012 8211
Advances in treatment of lung cancer with targeted therapy. Cagle, Philip T.; Chirieac, Lucian R. May 1, 2012 4883
Non-invasive mechanical ventilation therapy in patients with heart failure/Kalp yetersizligi hastalarinda noninvaziv mekanik ventilasyon tedavisi. Dursunoglu, Dursun; Dursunoglu, Nese Report May 1, 2012 5611
Asthma drug can help. Apr 20, 2012 117
TRAGIC GIRL, 5, DIES AFTER COUGH MEDICINE OVERDOSE; Toddler given twice recommended amount. Apr 18, 2012 219
Treatment combo beneficial in moderate to severe COPD. Tucker, Miriam E. Clinical report Apr 15, 2012 720
Research and Markets: Advances in Combination Therapy for Asthma and COPD. Apr 12, 2012 373
Starhaler[R] Device Finalist at Medical Design Excellence Awards. Apr 10, 2012 706
Pearl Therapeutics Creates Nanogram-Dose Inhalers and Initiates a Phase 2b Study to Characterize Ultra-low Doses of Glycopyrrolate. Apr 3, 2012 1016
QVA149 Phase III COPD Studies Met Primary Endpoints. Apr 2, 2012 1266
LUNGevity Announces New Link with LIVESTRONG. Apr 2, 2012 687
Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio. Apr 2, 2012 2052
Non-eosinophilic asthma. Klotter, Jule Brief article Apr 1, 2012 422
The effect of asthma on phonation: a controlled study of 34 patients. Asnaashari, Amir M.H.; Rezaei, Saman; Babaeian, Mahasti; Taiarani, Mohamad; Shakeri, Mohamad Taghi; Clinical report Apr 1, 2012 2404
Silence Therapeutics Plc: Unaudited Preliminary Results for the Year Ended 31 December 2011. Financial report Mar 21, 2012 8982
Asthma medication adherence poor, especially among women. Tucker, Miriam E. Mar 15, 2012 527
Research and Markets: Product Profiles: COPD in China - Novel Therapies to Diversify Treatment Options. Mar 5, 2012 427
Effect of ginger on chemotherapy-induced nausea and/or vomiting in cancer patients. Alparslan, Guler Balci; Ozkarman, Ayse; Eskin, Nuran; Yilmaz, Songul; Akay, Meltem; Acikgoz, Ayfer; Report Mar 1, 2012 2924
Synta Announces Review of Ganetespib Results in Lung Cancer Presented at IASLC 12th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting. Financial report Feb 29, 2012 1266
Forest and Almirall Announce Positive FDA Advisory Committee's Recommendation for Approval of Aclidinium Bromide for the Treatment of Chronic Obstructive Pulmonary Disease (COPD). Feb 24, 2012 849
CIRO+ and BIOMAX announce the first Data Center enabling patient stratification and targeted medicine in COPD. Feb 22, 2012 419
Requiring a Prescription for Cold Medicine Has Not Reduced Meth Use in Oregon. Feb 21, 2012 943
Pharmacists focus on asthma treatment. Feb 7, 2012 561
The association of health insurance and disease impairment with reported asthma prevalence in U.S. children. Coker, Tumaini R.; Kaplan, Robert M.; Chung, Paul J. Feb 1, 2012 5327
Acid reflux drug does not improve asthma symptoms in kids. Jan 25, 2012 379
Treatment of silent acid reflux does not improve asthma in children, NIH study finds. Brief article Jan 25, 2012 117

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters